May 15 2010
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/bsmd) has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of BioSphere Medical, Inc. ("BioSphere Medical" or the "Company") (NASDAQ:BSMD) in connection with their actions in causing BioSphere Medical to enter into a merger agreement with Merit Medical System, Inc. and Merit BioAcquisition Co., a wholly-owned subsidiary of Merit Medical pursuant to which BioSphere Medical will merge with and into Merit BioAcquisition Co.
Our investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Company's board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of BioSphere Medical. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at [email protected] or visit: www.rmclasslaw.com/cases/bsmd.
Under the terms of the agreement, each share of BioSphere Medical common stock will be exchanged for $4.38 per share in cash.
If you own shares of BioSphere Medical and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/bsmd. You may also email Mr. Maniskas at [email protected]. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.